Alipogene Tiparvovec for the Treatment of LPLD Patients

首次发布于 2016 年 9 月 19 日

Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

计划入组 19 人 · 首次发布于 2011 年 10 月 6 日

Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

计划入组 60 人 · 首次发布于 2010 年 12 月 8 日

Alipogene tiparvovec

CD19 (Allogene Therapeutics)

Recombinant hyaluronidase (Alteogen)

ALTEOGEN Inc.

South Korea

Allogene Therapeutics

United States

Alvogen, Inc.

United States

FDA Grants Rare Pediatric Disease Designation to AlveoGene's AVG-002 for SP-B Deficiency

Allogene Therapeutics Halts Enrollment in Leukemia Trial Cema-Cel Due to Slow Recruitment

Allogene's ALLO-316 Receives FDA RMAT Designation for Advanced Renal Cell Carcinoma